Vila-Guilera J, Ciric L, Parikh P, Dasgupta R, Lakhanpaul M. Comparing faecal transmission pathways contributing to enteric infections in infants in rural India. Poster presented at the 2021 RCPCH Conference; March 6, 2021. Singapore, China. [abstract] BMJ Paediatr Open. 2021 Apr 18; 5(Suppl 1):A36. doi: 10.1136/bmjpo-2021-RCPCH.69
John NM, Wright SJ, Gavan SP, Vass CM. The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic review. Eur J Health Econ. 2019 Nov;20(8):1123-31. doi: 10.1007/s10198-019-01082-x
Kamptner NL, Teyber FH, Rockwood NJ, Drzewiecki D. Evaluating the efficacy of an attachment-informed psychotherapeutic program for incarcerated parents. J Prison Educ Reentr. 2017 Dec;4(2):62-81.
Wilson MR, Bergman A, Chevrou-Severac H, Selby R, Smyth M, Kerrigan MC. Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom. Eur J Health Econ. 2017 Mar;19(2):229-40. doi: 10.1007/s10198-017-0879-5.
Ferrer P, Ballarín E, Sabate M, Laporte JR, Schoonen M, Rottenkolber M, Fortuny J, Hasford J, Tatt I, Ibanez L. Sources of European drug consumption data at a country level. Int J Public Health. 2014 Oct;59(5):877-87. doi: 10.1007/s00038-014-0564-8
Foraster M. Is it traffic-related air pollution or road traffic noise, or both? key questions not yet settled!. Int J Public Health. 2013 Oct;58(5):647-8. doi: 10.1007/s00038-013-0500-3
Foraster M. Editorial - Is it traffic-related air pollution or road traffic noise, or both? Key questions not yet settled!. Int J Public Health. 2013 Oct;58(5):647-8. doi: 10.1007/s00038-013-0500-3
Casas L, Zock JP, Carsin AE, Fernandez-Somoano A, Esplugues A, Santa-Marina L, Tardon A, Ballester F, Basterrechea M, Sunyer J. The use of household cleaning products during pregnancy and lower respiratory tract infections and wheezing during early life. Int J Public Health. 2013 Oct;58(5):757-64. doi: 10.1007/s00038-012-0417-2
Beard SM, von Scheele BG, Nuki G, Pearson IV. Cost-effectiveness of febuxostat in chronic gout. Eur J Health Econ. 2013 May;Advance online publication.
Greiner W, Lehmann K, Earnshaw S, Bug C, Sabatowski R. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany. Eur J Health Econ. 2006 Dec 1;7(4):290-6.
Lehmann K, Radbruch L, Gockel HH, Neighbors D, Nuyts G. Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Duragesic) with controlled release morphine. Eur J Health Econ. 2002;3:111-9. doi: 10.1007/s10198-002-0097-6.
Niaura R, Britt DM, Shadel WG, Goldstein M, Abrams D, Brown R. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav. 2001 Mar 1;15(1):13-7.